OpenEvidence closed a $250 million funding round, doubling its valuation to $12 billion as its ad-supported AI tool gains traction with US physicians.
The company is positioning this approach as a turning point for robotics, comparable to what large generative models have done for text and images.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback